UR9.STU CLINUVEL PHARMACE (UR9.SG)

Other Metals & Mining Stuttgart Exchange
- EUR
Market cap
-
P/E
11.4x
P/B
1.79x
ROE
12.4%
Dividend yield
0.22%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is UR9.STU undervalued?

Graham number

The Graham number of CLINUVEL PHARMACE (UR9.SG) cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CLINUVEL PHARMACE (UR9.SG) fundamental analysis

No fundamental analysis for CLINUVEL PHARMACE (UR9.SG) yet.

CLINUVEL PHARMACE (UR9.SG) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CLINUVEL PHARMACE (UR9.SG)

There is no Profile data available for UR9.SG.

Full company profile